These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27402654)

  • 21. Medication-assisted treatment with methadone: assessing the evidence.
    Fullerton CA; Kim M; Thomas CP; Lyman DR; Montejano LB; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
    Psychiatr Serv; 2014 Feb; 65(2):146-57. PubMed ID: 24248468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.
    Maremmani I; Gerra G
    Am J Addict; 2010; 19(6):557-68. PubMed ID: 20958853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated opioid use disorder and HIV treatment: rationale, clinical guidelines for addiction treatment, and review of interactions of antiretroviral agents and opioid agonist therapies.
    Batkis MF; Treisman GJ; Angelino AF
    AIDS Patient Care STDS; 2010 Jan; 24(1):15-22. PubMed ID: 20095910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis.
    McLinden T; Moodie EEM; Hamelin AM; Harper S; Rossi C; Walmsley SL; Rourke SB; Cooper C; Klein MB; Cox J
    Drug Alcohol Depend; 2018 Apr; 185():374-380. PubMed ID: 29544189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of opioid dependence in the setting of pregnancy.
    Young JL; Martin PR
    Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the Concepts of Abstinence and Recovery Through the Experiences of Long-Term Opiate Substitution Clients.
    Notley C; Blyth A; Maskrey V; Pinto H; Holland R
    Subst Abus; 2015; 36(2):232-9. PubMed ID: 25127184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for cannabis-based interventions in the opioid overdose crisis.
    Lucas P
    Harm Reduct J; 2017 Aug; 14(1):58. PubMed ID: 28821296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorder.
    Brar R; Sutherland C; Nolan S
    BMJ Case Rep; 2019 Aug; 12(7):. PubMed ID: 31371332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of Opioid-Related Death During Methadone Therapy.
    Leece P; Cavacuiti C; Macdonald EM; Gomes T; Kahan M; Srivastava A; Steele L; Luo J; Mamdani MM; Juurlink DN;
    J Subst Abuse Treat; 2015 Oct; 57():30-5. PubMed ID: 26014916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    Harris M; Rhodes T
    Int J Drug Policy; 2013 Nov; 24(6):e43-50. PubMed ID: 23199896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-Family Therapy with a Reflecting Team: A Preliminary Study on Efficacy among Opiate Addicts in Methadone Maintenance Treatment.
    Garrido-Fernández M; Marcos-Sierra JA; López-Jiménez A; Ochoa de Alda I
    J Marital Fam Ther; 2017 Apr; 43(2):338-351. PubMed ID: 27747887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome evaluation of the opioid agonist maintenance treatment in Iran.
    Esmaeili HR; Ziaddinni H; Nikravesh MR; Baneshi MR; Nakhaee N
    Drug Alcohol Rev; 2014 Mar; 33(2):186-93. PubMed ID: 24428135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Better efficacy of buprenorphine and methadone in opioid dependence. Requirements for abstinence from non-opioids before starting treatment paid off].
    Hoffmann O; Frisell F; Ljungberg T
    Lakartidningen; 2014 Jan 29-Feb 4; 111(5):147-9. PubMed ID: 24624763
    [No Abstract]   [Full Text] [Related]  

  • 35. Methadone is no panacea.
    Spence D
    BMJ; 2012 Aug; 345():e5670. PubMed ID: 22915733
    [No Abstract]   [Full Text] [Related]  

  • 36. Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision.
    Clark CB; Hendricks PS; Lane PS; Trent L; Cropsey KL
    Addict Behav; 2014 Dec; 39(12):1736-40. PubMed ID: 25117851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma.
    Holbrook AM
    Am J Drug Alcohol Abuse; 2015; 41(5):371-3. PubMed ID: 26154531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.
    Meyer MC; Johnston AM; Crocker AM; Heil SH
    J Addict Med; 2015; 9(2):81-6. PubMed ID: 25622120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management of opioid maintenance treatments when analgesic treatments are required].
    Laprevote V; Geoffroy PA; Rolland B; Leheup BF; Di Patrizio P; Cottencin O; Schwan R
    Presse Med; 2013; 42(7-8):1085-90. PubMed ID: 23518339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance.
    Jaremko KM; Sterling RC; Van Bockstaele EJ
    J Subst Abuse Treat; 2015 Jan; 48(1):117-27. PubMed ID: 25239858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.